Eluxadoline Catalog No.:M8654-10 InChi: InChI=1S/C15H9F2N5O3

InChi: InChI=1S/C15H9F2N5O3

InChi: InChI=1S/C23H24N2O

TAK-063 represents a promising drug for the treatment of schizophrenia with potential for superior safety and tolerability profiles

It was approved by US FDA in 2011 to treat castration-resistant prostate cancer

KRN633 is a potent and selective VEGFR inhibitor

Eluxadoline Catalog No.:M8654-10 InChi: InChI=1S/C15H9F2N5O3Eluxadoline is an orally active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea predominant irritable bowel syndrome (IBS D). Eluxadoline is a and opioid receptor agonist and opioid receptor antagonist that acts locally in the enteric nervous system, possibly decreasing adverse effects on the central nervous system. This product is discontinued (DEA Schedule IV). Product information CAS Number: 864821 90 9